Brought to you by 
Weihai Jierui to distribute ACell's wound products in China
27 Apr 2021
Executive Summary
Weihai Jierui Medical Products Co. Ltd. (a division of Shandong Weigao Group Medical Polymer Co. Ltd.) will exclusively distribute ACell Inc.’s wound matrix products in China and Hong Kong.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Weihai Jierui to distribute ACell's wound products in China
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice